UBC in the News: Post Haste

Post Haste

UBC in the News: Post Haste

Increasingly, payers and physicians are seeking real-world data on newly approved medications. Post-Authorisation Safety Studies (PASS) can provide this vital safety information and encourage market acceptance and uptake. Jess Sohal, MSc, Executive Director, Clinical Operations, Europe, outlines the operational planning necessary to launch a successful post-approval study in the November edition of International Clinical Trials. She covers key factors, including: 

• Operational team makeup
• Feasibility and site selection
• Timelines and critical pathways
• Site management and tools

Click here to read her article.

Learn more about PASS in our free whitepaper. Click here to get your copy.